SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Schedule 13G
Under the Securities Exchange Act of 1934
(Amendment No. )*
Clinicom Inc.
(Name of Issuer)
Common Stock
(Title of Class of Securities)
#187262108
(CUSIP Number)
Check the following box if a fee is being paid with this statement
X .
(A fee is not required only if the filing person: (1) has a
previous
statement on file reporting beneficial ownership of more than five
percent of
the class of securities described in Item 1; and (2) has filed no
amendment
subsequent thereto reporting beneficial ownership of five percent
or less of
such class.) (See Rule 13d-7.)
*The remainder of this cover page shall be filled out for a
reporting
person's initial filing on this form with respect to the subject
class of
securities, and for any subsequent amendment containing
information which
would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall
not be
deemed to be "filed" for the purpose of Section 18 of the
Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of
that section
of the Act but shall be subject to all other provisions of the Act
(however,
see the Notes).
(Continued on following pages(s))
Page 1 of 5 Pages
CUSIP No. 187262108 Page 2 of 5 Pages
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Dean Witter Health Sciences Trust
IRS No. 13-3674250
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) (b)
Not Applicable. Not Applicable.
3 SEC USE ONLY
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Massachusetts
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:
5 SOLE VOTING POWER
340,000 shares of common stock
6 SHARED VOTING POWER
7 SOLE DISPOSITIVE POWER
340,000
8 SHARED DISPOSITIVE POWER
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
340,000
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES*
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
5.060%
12 TYPE OF REPORTING PERSON*
IV
*SEE INSTRUCTION BEFORE FILLING OUT!
Schedule 13G
Issuer: Clinicom Inc.
CUSIP NO.:187262108
Item 1(a) Name of Issuer:
Clinicom Inc.
Item 1(b) Address of Issuer's Principal Executive Offices:
4720 Walnut Street
Boulder, Colorado 80301
Item 2(a) Name of Person Filing:
Dean Witter Health Sciences Trust
Item 2(b) Address of Principal Business Office:
Two World Trade Center, New York, NY 10048
Item 2(c) Citizenship:
Massachusetts
Item 2(d) Title of Class Securities:
Common Stock
Item 2(e) CUSIP Number:
187262108
Item 3 If this statement is filed pursuant to Rules 13d -
1(b), or 13d-2(b), check whether the person filing
is a:.
(a) ( ) Broker or Dealer registered under Section 15 of the
Act.
(b) ( ) Bank as defined in Section 3(a) (6) of the Act.
(c) ( ) Insurance Company as defined in Section 3(a) (19) of
the Act.
(d) (x) Investment Company registered under Section 8 of the
Investment Company Act.
Page 3 of 5 Pages
send/sch.13G.6<PAGE>
Item 4Ownership:
(a) Amount of Beneficially Owned:
340,000
(b) Percent of Class:
5.060%
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the
vote 340,000
(ii) shared power to vote or to direct the
vote -0-
(iii) sole power to dispose or to direct
the disposition of 340,000
(iv) shared power to dispose or to direct
the disposition of -0-
Item 5 Ownership of Five Percent or Less of a Class.
Not Applicable.
Item 6 Ownership of More than Five Percent on Behalf of
Another Person.
Not Applicable.
Item 7 Identification and Classification of the
Subsidiary Which Acquired the Security Being
Reported on By the Parent Holding Company.
Not Applicable.
Item 8 Identification and Classification of Members of
the Group.
Not Applicable.
Item 9 Notice of Dissolution of Group.
Not Applicable.
Page 4 of 5 Pages
send/sch.13G.6
<PAGE>
Item 10 Certification.
By signing below I certify that, to the best
of my knowledge and belief, the securities
referred to above were acquired in the ordinary
course of business and were not acquired for the
purpose of and do not have the effect of
changing or influencing the control of the issuer
of such securities and were not acquired in
connection with or as a participant in any
transaction having such purpose or effect.
SIGNATURE
After reasonable inquiry and to the best of my
knowledge and belief, I certify that the
information set forth in this statement is true,
complete and correct.
February 8, 1994
(Date)
/s/Ronald Worobel/Vice President
(Signature)
Ronald Worobel/Vice President
(Name/Title)
Page 5 of 5 Pages
send/sch13G.6